Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

2338 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Buspirone-associated Movement Disorder: A Literature Review

Rissardo JP, Caprara ALF.

Prague Med Rep. 2020;121(1):5-24. doi: 10.14712/23362936.2020.1.

A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes

Wong JK, Middlebrooks EH, Grewal SS, Almeida L, Hess CW, Okun MS.

Mov Disord. 2020 May;35(5):741-751. doi: 10.1002/mds.28045. Epub 2020 Apr 12.

Recommendations for Deep Brain Stimulation Device Management During a Pandemic

Miocinovic S, Ostrem JL, Okun MS, Bullinger KL, Riva-Posse P, Gross RE, Buetefisch CM.

J Parkinsons Dis. 2020;10(3):903-910. doi: 10.3233/JPD-202072.

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database

Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TTH.

BMC Psychiatry. 2020 Jun 16;20(1):308. doi: 10.1186/s12888-020-02711-z.

Corticobasal Syndrome in a Patient with Anti-IgLON5 Antibodies

Fuseya K, Kimura A, Yoshikura N, Yamada M, Hayashi Y, Shimohata T.

Mov Disord Clin Pract. 2020 May 5;7(5):557-559. doi: 10.1002/mdc3.12957. eCollection 2020 Jul.

Management of Tardive Syndrome: Medications and Surgical Treatments

Factor SA.

Neurotherapeutics. 2020 Oct;17(4):1694-1712. doi: 10.1007/s13311-020-00898-3.

Delayed Diagnoses of SGCE Myoclonus-Dystonia

Varga MG, Nand NP, LeDoux MS.

Tremor Other Hyperkinet Mov (N Y). 2020 Jul 28;10:23. doi: 10.5334/tohm.334.

Biomarkers in functional movement disorders: a systematic review

Thomsen BLC, Teodoro T, Edwards MJ.

J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1261-1269. doi: 10.1136/jnnp-2020-323141. Epub 2020 Oct 21.

Functional Movement Disorders in Children

Chouksey A, Pandey S.

Front Neurol. 2020 Nov 12;11:570151. doi: 10.3389/fneur.2020.570151. eCollection 2020.

Variability of Movement Disorders: The Influence of Sensation, Action, Cognition, and Emotions

Berlot R, Rothwell JC, Bhatia KP, Kojović M.

Mov Disord. 2021 Mar;36(3):581-593. doi: 10.1002/mds.28415. Epub 2020 Dec 17.

Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development

Rasetti-Escargueil C, Popoff MR.

Toxins (Basel). 2020 Dec 22;13(1):1. doi: 10.3390/toxins13010001.

Sex differences in movement disorders

Meoni S, Macerollo A, Moro E.

Nat Rev Neurol. 2020 Feb;16(2):84-96. doi: 10.1038/s41582-019-0294-x. Epub 2020 Jan 3.

Armand Trousseau (1801-1867), a neurologist before neurology

Walusinski O.

Rev Neurol (Paris). 2020 Sep;176(7-8):531-542. doi: 10.1016/j.neurol.2019.12.002. Epub 2020 Jan 7.

Maximizing placebo response in neurological clinical practice

Mariani LL, Corvol JC.

Int Rev Neurobiol. 2020;153:71-101. doi: 10.1016/bs.irn.2020.04.003. Epub 2020 Jun 9.

Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D(2) Dopamine Receptor (D(2)-R) Isoforms

Blagotinšek Cokan K, Mavri M, Rutland CS, Glišić S, Senćanski M, Vrecl M, Kubale V.

Biomolecules. 2020 Sep 23;10(10):1355. doi: 10.3390/biom10101355.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias